Media Alert: 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction

Contact: Sam Roth,,

WASHINGTON (Apr 19, 2023) -

The 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction will publish online on Wednesday, April 19, 2023, at 2:00 p.m. ET in the Journal of the American College of Cardiology.

Heart failure (HF) is a chronic condition that is usually manageable with medication and lifestyle changes, however, it remains a major cause of death worldwide. Heart failure with preserved ejection fraction (HFpEF) occurs when the heart is pumping regularly, but the heart muscle is stiff and cannot relax to fill with blood. Although it is often underrecognized, more than 50% of individuals with heart failure have HFpEF. Considering favorable clinical trial results assessing newer therapies, the Expert Consensus Decision Pathway (ECDP) writing committee addresses the important differences in diagnostic criteria based on gender, and details practical treatment strategies of HFpEF. The document builds upon the recommendations from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.

Recognizing HF can often come with multiple overlapping comorbidities, including hypertension, diabetes, obesity and sleep apnea, this document emphasizes the importance of a multidisciplinary care team approach to provide the full scope of care for patients. It lays out a structure for clinical decision-making, management of comorbidities, implementation of the latest guideline directed medical therapy (pharmacological and non-pharmacological) and equitable delivery of care. 

In a JACC Scientific Statement, developed in a complementary fashion, the JACC Editorial Board and ACC Heart Failure and Transplant Section provides an in-depth analysis of the current epidemiology, pathophysiology, diagnosis and treatment of HFpEF. The Scientific Statement also addresses knowledge gaps in care and future therapeutic strategies.

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelinesThrough its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring aworld where science, knowledge and innovation optimize patient care and outcomes. Learn more at or follow @ACCinTouch.

The ACC’s family of JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and family of specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at


< Back to Listings